Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Stroke in Pregnancy

By Howard Roemer, M.D.; Paul L. Ogburn Jr., M.D.; Vern L. Katz, M.D.; Anna Wanahita, M.D.; and Robert Crane, M.D. | on February 1, 2012 | 0 Comment
From the College
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Surgical or endovascular treatment of ruptured aneurysms during pregnancy may be associated with improved maternal-fetal outcomes. Benefits are less clear with AVMs. A decision to deliver or continue pregnancy is best coordinated with specialty team.

You Might Also Like
  • Sepsis in Pregnancy
  • Critical Issues in the Initial Evaluation and Management of Patients Presenting to the Emergency Department in Early Pregnancy
  • Drugs of Abuse in Pregnancy
Explore This Issue
ACEP News: Vol 31 – No 02 – February 2012

Blood Pressure Control

Hemorrhagic Stroke

A set of AHA/ASA guideline recommendations (Class C) have been published for nonpregnant patients with hemorrhagic stroke.19 If the patient also has pre-eclampsia/eclampsia (which should be assumed after 20 weeks of pregnancy), the exact targets may need to be coordinated with neurology, neurosurgery, and OB consultants. Also, magnesium sulfate should be used prophylactically to prevent seizures in pre-eclampsia/eclampsia, which can exacerbate the severity of hemorrhagic stroke and elevated blood pressures.

Drug treatment for pre-eclampsia/eclampsia is usually reserved for patients with BP greater than 160 systolic and greater than 110 diastolic. Avoid lowering blood pressure below 140/90 because of the possible untoward consequence of uterine hypoperfusion.20

Ischemic Stroke

In the pregnant patient, a significantly elevated BP may be detrimental to the pregnancy, especially when associated with pre-eclampsia. This condition requires treatment with magnesium sulfate, which promotes vasodilation and prevents seizures. Symptomatic hypoxic neurologic injury associated with ischemic brain pathology caused by occlusive vasospasm of pre-eclampsia (and demonstrated on MRI) is frequently completely reversed by conservative management that includes the use of magnesium sulfate, expedited delivery of the fetus and placenta, and management of any additional complications associated with pre-eclampsia.

Blood Pressure Drugs

Optimal drugs have not been well studied in pregnant patients. Strongly consider pre-eclampsia when significant hypertension is present. A consulting team can help select the best option. Labetalol drip, commonly recommended in pre-eclampsia, is a widely used option.

Limited experience with nicardipine has shown it to be an effective antihypertensive agent in severe pre-eclampsia and in pregnant women with autonomic hyperreflexia. So far, nicardipine has not been shown to have any deleterious effect on neonatal outcomes, even when an overdose was accidentally given to one patient. To avoid undesired precipitous drops in BP, consider an initial dose of 2.5 mg/hour without a bolus and the use of an arterial line for continuous BP monitoring. Close clinical surveillance in the postpartum period is mandatory because of a possible increased risk for uterine atony after treatment with nicardipine.21

One study showed patients treated with nicardipine were more likely to reach a physician-specified systolic BP target range within 30 minutes versus those treated with labetalol.22

Antiepileptics

Assume seizures are caused by eclampsia (after 20 weeks of pregnancy)23 even if BP is not elevated. Also assume there is risk for seizures with the diagnosis of pre-eclampsia and progressive hypertension or other neurologic symptoms. In either case, initiate magnesium sulfate therapy to decrease risk of new or recurrent seizures, according to the following protocol:

  • Give a 4- to 6-g IV loading dose over 15-20 minutes.
  • Give a maintenance infusion at 2 g/hour.
  • Check DTRs, urine output, and respiratory rate hourly. For depressed DTRs or oliguria, stop infusion and check serum magnesium level. For magnesium overdose, administer 1 g of calcium gluconate via a slow IV push.
  • Treat a breakthrough seizure with a 2-g bolus over 3 minutes. If ineffective, consider sodium amobarbital 250 mg IV over 3-5 minutes, lorazepam 1-2 mg/min IV up to 10 mg, or diazepam 2 mg/min up to 20 mg. Lorazepam has a longer duration of action. These drugs, especially in combination with magnesium, may result in substantial maternal and neonatal respiratory depression.
  • Consider RSI as necessary.

Benzodiazepines are used as in nonpregnant patients for terminating acute seizures. These drugs may affect fetal heart rate variability. Initial stabilization with a fosphenytoin loading dose or benzodiazepine drip are acceptable options. Refractory cases can be treated with propofol.24,25

Pages: 1 2 3 4 5 | Single Page

Topics: Airway ManagementBlood PressureCardiovascularClinical GuidelineCritical CareEmergency MedicineEmergency PhysicianHypertensionOB/GYNOB/GYN TraumaPharmaceuticalsPregnancyProcedures and SkillsStroke

Related

  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • November 2025 News from the College

    November 4, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “Stroke in Pregnancy”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603